Kim Björnstrup
Voorzitter bij Assistance Hr Partners A/S
Profiel
Kim Björnstrup is currently the Chairman of Assistance Hr Partners A, Director of Aase Hagemann Holding ApS, Director of Assistance Gastronomie A, and Director of Hagemann Ejendomme A.
In the past, he served as the Chief Executive Officer of Bio Products Laboratory Holdings Ltd.
from 2013 to 2014, Deputy Chairman of Octapharma AG from 1992 to 2010, Chairman of Veloxis Pharmaceuticals A, Chairman of Evaxion Biotech A, and Director of Xeltis AG.
He graduated from the University of Copenhagen.
Actieve functies van Kim Björnstrup
| Bedrijven | Functie | Begin |
|---|---|---|
Assistance Hr Partners A/S
 Assistance Hr Partners A/S Personnel ServicesCommercial Services Assistance HR Partners A/S provides staffing services. The private company is based in Frederiksberg, Denmark. | Voorzitter | - |
| Aase Hagemann Holding ApS | Directeur/Bestuurslid | - |
| Assistance Gastronomie A/S | Directeur/Bestuurslid | - |
| Hagemann Ejendomme A/S | Directeur/Bestuurslid | - |
Eerdere bekende functies van Kim Björnstrup
| Bedrijven | Functie | Einde |
|---|---|---|
Bio Products Laboratory Holdings Ltd.
 Bio Products Laboratory Holdings Ltd. Medical DistributorsDistribution Services Bio Products Laboratory Holdings Ltd. operates as a holding company with interests in distributing blood plasma products. It operates business through two subsidiaries which include Bio Products Laboratory Ltd. and DCI Biologicals, Inc. The company was founded on 16 October 2002 is headquartered in London, the United Kingdom. | Algemeen Directeur | 01-05-2014 |
Octapharma AG
 Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | Directeur/Bestuurslid | 01-10-2010 |
| EVAXION BIOTECH A/S | Voorzitter | - |
Xeltis AG
 Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Directeur/Bestuurslid | - |
| VELOXIS PHARMACEUTICALS A/S | Voorzitter | - |
Opleiding van Kim Björnstrup
| University of Copenhagen | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| EVAXION BIOTECH A/S | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Octapharma AG
Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | Health Technology |
Bio Products Laboratory Holdings Ltd.
Bio Products Laboratory Holdings Ltd. Medical DistributorsDistribution Services Bio Products Laboratory Holdings Ltd. operates as a holding company with interests in distributing blood plasma products. It operates business through two subsidiaries which include Bio Products Laboratory Ltd. and DCI Biologicals, Inc. The company was founded on 16 October 2002 is headquartered in London, the United Kingdom. | Distribution Services |
| Aase Hagemann Holding ApS | |
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Health Technology |
| Assistance Gastronomie A/S | |
| Hagemann Ejendomme A/S | |
Assistance Hr Partners A/S
Assistance Hr Partners A/S Personnel ServicesCommercial Services Assistance HR Partners A/S provides staffing services. The private company is based in Frederiksberg, Denmark. | Commercial Services |
